🆕➡️Do you need support with non-CTIMP research, clinical audits, evaluations or project databases? Introducing Research FIRST - our Flexible, Innovative Research Support Team working across @BHPComms. Meet the team and learn more about the service here > https://t.co/H3VCKsUVfx
Our first NIHR Birmingham BRC newsletter is out now!
Catch up on research news, events and updates from across the Centre.
📄 Read Issue 1:
https://t.co/WVdBJWYow5
📬 Sign up to get future editions every 2 months:
https://t.co/ErNQOM23WC
Life‑saving cancer immunotherapy can cause severe arthritis in at least 5% of patients. The new REACT trial is testing how to treat it safely.
Participant Becky (pictured below), said: “I couldn’t get out of bed… [The trial] has been a godsend.”
🔗 https://t.co/ErHaULX713
👩🔬 Selly Oak teens can now explore the world of medical innovation thanks to our partnership with local schools, convened by @AlistairCarns MP. Students can learn skills from device design & development to materials science in our medtech Makerspace⬇️⬇️
https://t.co/LKPjOhX1uQ
Final places available 🚀
Our first PHTA Founder Growth Series workshop focuses on sales management for early-stage life science founders: practical tools + clear processes = real growth.
🗓️ 26 Feb | 🕑 2–5pm
Register: https://t.co/lz61I0D1pm
🩻 A UK-first trial led by Birmingham researchers aims to improve treatment of arthritis in people who have developed the condition as a result of cancer immunotherapy ⬇️
https://t.co/c3wNGqUtZ5 @BirminghamBRC@CRCTU
.@unibirmingham's @elsadiabetes study is rewriting the story of type 1 diabetes, showing that childhood screening can detect it years before symptoms appear. Instead of an unexpected crisis, families can plan ahead- accessing treatments to delay onset - https://t.co/pbYpvmYkJ8
We're excited to host the 119th Annual Meeting of the Association of Physicians of Great Britain and Ireland (AoPGBI) at @unibirmingham.
Abstract submission is now open to share your work and participate until 16 February. ⬇️ #APAM2026
2/2 - The Minister also toured our Makerspace and @CISUoB, as well as meeting local medtech success stories and representatives from @WestMids_CA and @pearson who were instrumental in designing the new qualification. Thank you for joining us, Baroness @Jacqui_Smith1!
Last week Baroness @Jacqui_Smith1, Minister for Skills, chose PHTA as the setting for the launch of the new MedTech HTQ - underlining growing national recognition of Birmingham’s health and life sciences district as a focal point for sector innovation 1/2
https://t.co/f8ifCzZJC1
Birmingham’s health and life sciences district is emerging as a powerful engine for growth - driving jobs, inward investment and globally-relevant research. Read @unibirm_CMH's Prof Neil Hanley's thoughts on how we're helping to strengthen the sector 👇
https://t.co/qmeg3Nvq0T
🔬🧪🥼 Applications are now open for the @CR_UK Clinical Academic Training Programme at @unibirm_CMH!
It offers fully-funded clinical PhD fellowships in cancer immunology, genomics, or the tumour microenvironment.
Apply by 2nd Feb 2026 >> https://t.co/FsJrapms7B
The @DaRe2ThinkTrial has launched a new digital platform to transform how NHS GP practices take part in clinical trials - reducing paperwork for GP staff and reaching communities often underrepresented in research >
https://t.co/DAyviTuptX @NIHRrdn@MHRAgovuk
💫 BHP's year in review!
Our 2024-25 annual review launches today, feat:
💷 £70m of research investments from @NIHRresearch and other funders
🤝 New partnership with @UK_ABHI
🏆 Launch of BHP People reward scheme
👥 PPIE programme expanded
Read more: https://t.co/tNDuBu5JDo
We recently introduced the LifeARC Centre for Acceleration of Rare Disease Trials, hosted at @BCFC. We engaged with members of the public often underrepresented in research, sharing information about rare conditions, research and genetics.
Find out more: https://t.co/IvolwPHmiV
Our health inequalities theme lead Professor @JohtChandan has been awarded one of six prestigious @NIHRresearch Research Professorships, where he'll work to create safer, more supportive health services for survivors of violence against women and girls 👇 https://t.co/GkGFL9ERSX
📢 We're delighted to announce the appointment of Prof Andrew Filer (@a_filer) as our new Birmingham BRC Director!
Andrew takes over from Prof Paul Moss, who has served as our Interim Director since June 2024.
Read more about Andrew's appointment: https://t.co/O4SW4XM3K1
Prof Andrew Filer has been appointed as the new Director of the @BirminghamBRC. His leadership will further guide the BRC in delivering cutting-edge research that transforms patient care across the region and beyond. @uhbtrust@NIHRresearch@unibirmingham https://t.co/6WJhwJMC0B
The @MedilinkMids Business Awards 2026 are open! 🎉
Celebrating innovation across life sciences & medtech on 23 April, Leicester.
Apply now or explore sponsorships 👉 https://t.co/ObNOgt9k7n
💉 A global trial has found that a new treatment for a very rare skin cancer - Cutaneous (skin) T-cell Lymphoma - can improve survival rates for patients who have relapsed or have not responded to other treatments. BHP's @uhbtrust led the study in the UK > https://t.co/IDAg4koKMZ